XBIT stock forecast
Our latest prediction for XBiotech, Inc.'s stock price was made on the June 4, 2019 when the stock price was at 7.12$.
In the short term (2weeks), XBIT's stock price should outperform the market by 4.75%. During that period the price should oscillate between -7.92% and +15.27%.
In the medium term (3months), XBIT's stock price should outperform the market by 4.55%. During that period the price should oscillate between -18.01% and +36.02%.
Get email alertsCreate a solid portfolio with XBIT
About XBiotech, Inc.
XBiotech, Inc. is a biopharmaceutical company. The firm engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a profit of 14.44$ per share.
The book value per share is 1.44$
Three months stock forecastJune 4, 2019
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -31M | - | 669M | 14.44 | - | - | 46M | 1.44 | -18M | - | -18M |